#chemotherapy — Thursday, July 23, 2026 (2 items)
| 0 | ℹ |
Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer.
(nejm.org)
|
New England Journal of Medicine 2026-07-23 | #clinical trial #immunotherapy #bladder cancer #chemotherapy #neoadjuvant | |
| 0 | ℹ |
Mitochondrial metabolism determines chemotherapy sensitivity in colorectal cancer.
(nature.com)
|
Nature Metabolism 2026-07-23 | #chemotherapy #colorectal cancer #drug resistance #metabolism #mitochondria |